Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astrazeneca, Bionomics, Dr. Reddy’s, Regimmune, RQ, Simcere, Sirnaomics, Takeda.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen Medical, Alphamab Oncology, Ascletis, Asieris, Aslan, Astellas, Bioved, Recbio Technology, Tessa.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aim Immunotech, Createrna Science and Technology, Daiichi Sankyo, Immuneoncia, Innovent Biologics, Kinarus, Lynk, Qilu, Union.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Atea, Biogen, Clover, Eisai, H. Lundbeck, Henlius, Intravacc, Kintor, Kira, Otsuka, Providence, Qilu, Qurient, Sorrento, Vaxxinity.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Affibody, Atom Bioscience, Bridge, Enanta, Inmagene, Novavax, Que Oncology, Resolve, Sirnaomics, Telix, Vaxxas.